The set of Endoret® technology (prgf®) formulations represent a solution in terms of safety, efficacy and reproducibility that ophthalmologists demanded in the treatment of various ocular pathologies.

Know more

The fibrin-free growth factor-rich plasma formulation has been developed for daily use, is stored at room temperature, and can be used anywhere, anytime.

Autologous fibrin formulations of plasma rich in growth factors act as a scaffold in eye surgeries, accelerating recovery, improving visual acuity and decreasing pain and inflammation and reducing fibrosis.



Centro de investigación

PRGF autologous eye drops

  • Fibrin-free autologous plasma formulation
  • Quick and easy to prepare, without dilutions
  • Accelerates tissue regeneration due to its high concentration of growth factors that promote cell proliferation and migration
  • High anti-fibrotic potential that favors corneal transparency and protects against corneal scars and leukoma
  • Daily treatment without the need to store in the refrigerator that can be used anywhere and at any time
  • Autologous eye drops are used in pathologies such as:

    • Moderate and severe dry eye
    • Persistent Epithelial Defects
    • Corrective Surgery for Ametropia



Inmunosafe autologous eye drops

  • Autologous eyewash with ImmuneSafe treatment helps patients with conditions in which the immune system plays a significant role such as Sjögren's syndrome and graft-versus-host disease.
Centro de investigación



Centro de investigación

Plasma rich in growth factors autologous fibrin formulations in ophthalmology

Using the different autologous fibrin formulations improves eye surgery treatments such as:

  • Pterygium surgery
  • Reconstructive eye surgery
  • Symblepharon surgery
  • Corneal defects
  • Corneal ulcers
  • Glaucoma surgery
Do you want to know more about Endoret® (PRGF®)?
Related documents
Endoret® (prgf®) technology in Ophthalmology

Endoret® (prgf®) technology in Ophthalmology

Biological regeneration of ocular tissues

Size 3.24 Mb